There are 125 performance-based and parent reported items on the test in the following four areas of functioning: fine motor-adaptive, gross motor, personal-social, and language skills. Items are in sub-sample categories including race, less educated parents, and place of residence. Children are given up to 3 trials per task before moving on. 
Administrators are to have child perform easies tasks first and praise the child’s efforts despite success or failure. Administration: trained professional-clinical, teacher or early childhood professional. Time Requirements: takes about 20-30 min to administer and interpret. Target Population and Ages: birth to 6 years of age. Type of Test: First-level comprehensive screening. Purpose: screening for developmental problems to confirm suspected problems using an objective measure to monitor children at risk for developmental delay. Costs (booklets, forms, kit): The following items and others can be found at :. More information and products can be found at. Produced by Denver Developmental Materials, Inc. Source (publisher or distributor, address):. Author (s): Frankenburg, WK, Dodds, J., Archers, P., Shapiro, H., Bresnick, B. Title, Edition, Dates of Publication and Revision*: Denver Developmental Screening Test 2 nd ed (DDST II) 1960, 1990. We conclude that DDST II at 6 months of age could be used in predicting severe neurological outcome in infants with HIE.Posted on: Ma| By: achristian5 | Filed under: Denver Developmental Screening Test-2nd ed (DDST-II) However, DDST II at 6 months of age, yielded a very high predictive accuracy (sensitivity=100%, specificity=95%). 
Cranial US had 100% sensitivity, however with a rather low specificity (55%).
Among the predictors of severe adverse outcome, occurrence of seizures was found to have a poor predictive accuracy. Twenty of the remaining 47 infants had a severe adverse outcome. Of the 57 infants, 10 were lost to follow-up. Occurrence of seizures during the first 24 h, cranial ultrasonography (US) findings within the first 5 days of life, and Denver developmental screening test II (DDST II) at 6 months of age, were analyzed in relation to mortality and neurological status at 2 years of age. The primary aim of this study was to find widely available, inexpensive, and non-invasive parameters for early identification or prediction of the infants with hypoxic-ischemic encephalopathy (HIE) who will have a severe adverse outcome (classified as death or a major neurological deficit).įifty-seven full-term or near-term newborn infants with a diagnosis of HIE were consecutively admitted to the neonatal intensive care unit and studied.
0 kommentar(er)
